Nanobiotix S.A. (NBTX)
$23.68+3.41%Close
SELLCRISIS · day 28
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.2B
- Beta
- 0.57
- P/E (TTM)
- -20.49
- Short % float
- 0.36%
- Days to cover
- 1.0
- SI change
- -16.6%
- 1W
- -8.04%
- 1M
- -37.02%
- vs SPY 1W
- -9.20%
- vs SPY 1M
- -40.01%
Industry peers
FMP comparable companies · ranked by market cap
- GHRSSELLGH Research PLC$1.5BCRISISQ 16$22.17+3.23%
- TYRASELLTyra Biosciences, Inc.$1.2BCRISISQ 5$20.93-0.15%
- SVRASELLSavara Inc.$980MRECOVERYQ 11$4.78+1.86%
- KURASELLKura Oncology, Inc.$943MBEARQ 12$10.62+0.76%
- ABUSSELLArbutus Biopharma Corp$923MCRISISQ 13$4.67+0.96%
- PROKSELLProKidney Corp.$531MRECOVERYQ 1$1.58+4.82%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 6
- VALUE
- 12
- GROWTH
- 8
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC53.8%
REV YoY-
ROE89.7%
EPS YoY-
ROA-41.2%
GROSS100
OP-368
NET-618
[VALUATION]
P/E TTM-20.49
P/E FWD-
SECTOR PE20.47
INDUSTRY PE13.95
P/B-33.01
P/FCF-
EV/EBITDA-35.43
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.44
ND/EBITDA-
BETA0.57
